Test Video Page

[fullwidth background_color=”” background_image=”” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ background_repeat=”no-repeat” background_position=”left top” video_url=”” video_aspect_ratio=”16:9″ video_webm=”” video_mp4=”” video_ogv=”” video_preview_image=”” overlay_color=”” overlay_opacity=”0.5″ video_mute=”yes” video_loop=”yes” fade=”no” border_size=”0px” border_color=”” border_style=”” padding_top=”20″ padding_bottom=”20″ padding_left=”” padding_right=”” hundred_percent=”no” equal_height_columns=”no” hide_on_mobile=”no” menu_anchor=”” class=”” id=””][title size=”2″ content_align=”left” style_type=”single dashed” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””]UAMS Videos[/title][fusion_text]
Why should I be treated at an academic medical center?
What do I need to know about multiple myeloma?
Drug Trial for Castleman’s Gets Amazing Results
Why should I travel to Arkansas to be treated for multiple myeloma?
Andy Shapira - A Patient Testomonial
David Fajgenbaum Survivor Story
My advice to myeloma patients
UAMS -- Cancer and Myeloma Treatment -- Sean's Story
Expert Perspective: Optimizing Care Through Clinical Trials for Myeloma
Expert Perspective: Maximizing and Understanding Myeloma Treatment Approaches
Inspiring and Encouraging Words From a Myeloma Survivor
Care Partner Support: Working Together as a Couple
An Explanation of Myeloma
Choosing Treatment for YOUR Myeloma
Transplant as an Effective Treatment for Multiple Myeloma
How Oncology Social Workers Can Help
How to Take of Yourself and Prevent Infection With Myeloma
An Expert Explains Why to Consider a Myeloma Clinical Trial
Where Does Immunotherapy Fit in With Myeloma Treatment?
Myeloma Remission: Managing Life After Treatment
Should Multiple Myeloma Patients Undergo Genetic Testing?
Myeloma 2016: Panel discussion on the status of genomics
Myeloma 2016: Panel discussion on the new treatment paradigm
The mechanisms driving relapse in multiple myeloma
The clinical implications of progenitor cells in multiple myeloma
Identification of high-risk disease using molecular profiling by Mymap
The FORTE clinical trial of carfilzomib in multiple myeloma
Utilizing new understanding in multiple myeloma biology to guide treatment
Is FISH becoming obsolete in multiple myeloma?
Treatment at first relapse in multiple myeloma: how to choose a drug?
An all-molecular diagnostic approach for myeloma
The importance of the microenvironment in multiple myeloma
Novel kinase targets as emerging therapies for multiple myeloma
Are we ready for mutational directed treatment: addressing the genomic basis of myeloma
Frontline treatment for young multiple myeloma patients
Goals of Therapy for Symptomatic Myeloma
Risk Stratification for Myeloma
MRD Negativity in Multiple Myeloma
Optimal Timing for Transplantation in Myeloma
Living Well With Multiple Myeloma: Understanding Genetics and Developing Research
Why do many MM patients relapse after being treated with targeted therapy?
Will Circulating Tumor DNA Test Replace Bone Biopsy Test in Myeloma?
Does a Myeloma Patient Need to Be in Remission to Benefit From the Black Swan Initiative?
Any Updates on the Use of the New Immuno-Drugs for Maintenance in Myeloma?
Why Doesn’t Transplant Cure Multiple Myeloma?
Should I Discontinue or Continue Revlimid If I Remain MRD Negative?
ASH 2017: Are Experts Personalizing Therapy to the Genetics of a Patient’s Myeloma
Myeloma Crowd Roundtable Jackson 2017: Myeloma Expert Panel Q & A (morning session)
Myeloma Crowd Roundtable Jackson 2017: Myeloma Genomics by Faith Davies, MD
Myeloma Crowd Roundtable Jackson 2017: Monitoring Your Disease by Gareth Morgan, MD
Myeloma Crowd Roundtable Jackson 2017: Myeloma Expert Panel Q & A (afternoon session)
MCRT Jackson 2017: Personalized Medicine by Gareth Morgan, MD
Lymphoma & Myeloma 2017: Sequencing the genome in myeloma: Pitfalls and opportunities in the clinic by Dr. Gareth Morgan
ASH 2017: Novel oncogenes and tumor suppressor genes in newly diagnosed multiple myeloma by Dr. Gareth Morgan
Myeloma 2017: Game-changing drug classes for multiple myeloma by Dr. Gareth Morgan
Myeloma 2017: Why one size should not fit all for multiple myeloma by Dr. Gareth Morgan
Myeloma 2017: Identifying the drivers of multiple myeloma by Dr. Gareth Morgan
The Myeloma Genome Project: Designing personalized therapy for multiple myeloma by Dr. Gareth Morgan
The myeloma genome project and the aim to disseminate this worldwide by Dr. Gareth Morgan
The genetics of multiple myeloma and how we can use it to improve outcomes by Dr. Gareth Morgan
[/fusion_text][separator style_type=”none” top_margin=”30px” bottom_margin=”15px” sep_color=”” border_size=”” icon=”” icon_circle=”” icon_circle_color=”” width=”” alignment=”center” class=”” id=””][title size=”2″ content_align=”left” style_type=”single dashed” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””]Patient Power Videos[/title][imageframe lightbox=”no” gallery_id=”” lightbox_image=”” style_type=”none” hover_type=”none” bordercolor=”” bordersize=”0px” borderradius=”0″ stylecolor=”” align=”none” link=”http://myeloma.uams.edu/patient-power/” linktarget=”_self” animation_type=”0″ animation_direction=”down” animation_speed=”0.1″ animation_offset=”” hide_on_mobile=”no” class=”” id=””] [/imageframe][separator style_type=”none” top_margin=”30px” bottom_margin=”15px” sep_color=”” border_size=”” icon=”” icon_circle=”” icon_circle_color=”” width=”” alignment=”center” class=”” id=””][title size=”2″ content_align=”left” style_type=”single dashed” sep_color=”” margin_top=”” margin_bottom=”” class=”” id=””]Video Journal of Hemalotogical Oncology[/title][fusion_text]Gareth Morgan M.D. Videos
Faith Davies M.D. Videos[/fusion_text][/fullwidth]